Found: 68 articles

Article Edition
A.V. Kuzmenko, V.V. Kuzmenko, T.A. Gyaurgiev
Comparative analysis of the effectiveness of early and delayed initiation of combined DRUG therapy for bph
№2 / 2021
A.V. Kuzmenko, V.V. Kuzmenko, T.A. Gyaurgiev
Entomological drug adenosine for the treatment of patients with benign prostatic hyperplasia and chronic prostatitis
№1 / 2021
A.I. Neymark, B.A. Neymark, A.V. Davydov, N.A. Nozdrachev, I.V. Kablova, Ya.V. Yakovets, V.P. Levin
Possibilities of using sildenafil in patients with cardiovascular comorbidities who underwent transurethral resection of the prostate
№6 / 2020
V.V. Borisov
Combination of α1-blockers and phosphodiesterase type 5 inhibitor in patients with benign prostatic hyperplasia and erectile dysfunction: results of observatory prospective multicenter study
№3 / 2020
O.I. Bratchikov, I.A. Tyuzikov, S.O. Artishchev, E.A. Shumakova
The role of obesity in the pathogenesis of benign prostatic hyperplasia
№2 / 2020
D.V. Ergakov, A.G. Martov, D.E. Turin, A.S. Andronov
Lower urinary tract symptoms after transurethral resection of the prostate
№1 / 2020
A.A. Kaputovskij
Tadalafil 5 mg once daily is a rationale option for simultaneous treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction
№6 / 2019
V.Yu. Startsev, V.A. Dudarev, F.A. Sevryukov, N.B. Zabrodina
Economic aspects of treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia
№6 / 2019
V.A. Khokhlova, P.B. Rosnitskiy, S.A. Tsysar, S.V. Buravkov, O.A. Sapozhnikov, M.M. Karzova, T.D. Khokhlova, A.D. Maxwell, N.M. Gaifullin, A.V. Kadrev, D.A. Okhobotov, A.A. Kamalov, G.R. Schade
A novel method for non-invasive mechanical ablation of prostate tumors using pulsed focused ultrasound
№6 / 2019
A.N. Nizov
Efficacy of 5α-reductase inhibitors in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia
№5 / 2019
P.V. Glybochko, Z.K. Gadzhievа, Yu.G. Alyaev, M.A. Gazimiev
Multidisciplinary approach in urology. Clinical aspects
№4 (приложение) / 2019
I.V. Kuz’min
Vitaprost Forte in the treament of patients with benign prostatic hyperplasia: pathogenetic basics and clinical results
№4 / 2019


Бионика Медиа